Suma Krishnan's Net Worth
$323 Million
Who is Suma Krishnan?
Suma Krishnan has an estimated net worth of $323 Million. This is based on reported shares across multiple companies, which include NEW RIVER PHARMACEUTICALS INC, Krystal Biotech, Inc., and INTREXON CORP.
SEC CIK
Suma Krishnan's CIK is 0001298711
Past Insider Trading and Trends
2006 was Suma Krishnan's most active year for acquiring shares with 7 total transactions. Suma Krishnan's most active month to acquire stocks was the month of January. 2023 was Suma Krishnan's most active year for disposing of shares, totalling 25 transactions. Suma Krishnan's most active month to dispose stocks was the month of November. 2017 saw Suma Krishnan paying a total of $1,000,000.00 for 100,000 shares, this is the most they've acquired in one year. In 2006 Suma Krishnan cashed out on 396,800 shares for a total of $9,294,129.04, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
NEW RIVER PHARMACEUTICALS INC No price found
Vice President, Product Dev.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 25
| |||
Form 4
| -100.00% | -31.00K |
$25.58 | -$4,239,118.79 |
0
|
Nov 9 - Nov 10
| |||
Form 4
|
—
|
0
|
$30.33 | -$2,341,935.00 | 31K |
Oct 25
| |||
Form 4
|
—
|
0
|
$16.58 | -$758,038.25 | 31K |
Scheduled
|
May 18
| ||
Form 4
|
—
|
0
|
$16.06 | -$888,237.00 | 31K |
Scheduled
|
Mar 20
| ||
Form 4
|
—
|
0
|
$16.11 | -$2,822,038.05 | 65.64K |
Feb 13 - Feb 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 19
| |||
Form 4
| -16.22% | -3.00K |
$26.92 | -$251,722.50 | 15.5K |
Scheduled
|
Nov 22
| ||
Form 4
|
—
|
0
|
$21.87 | -$2,058,886.80 | 500 |
Scheduled
|
Sep 9
| ||
Form 4
|
∞
| 15K |
$22.14 | -$230,903.57 | 1K |
Scheduled
|
Sep 1 - Sep 6
| ||
Form 4
| -21.28% | -5.00K |
$36.95 | -$184,750.00 | 18.5K |
Scheduled
|
Aug 19
| ||
Form 4
|
—
|
0
|
$16.25 | -$302,500.00 | 8K |
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 29
| |||
Form 4
| +213.33% | 16K |
$2.50 | $40,000.00 | 23.5K |
Feb 25
| |||
Form 4
|
∞
| 500 |
$8.00 | $4,000.00 | 500 |
Aug 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Krystal Biotech, Inc. (KRYS) Snapshot price: $184.19
President, R&D
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -1.61% | -50.00K |
$197.77 | -$9,888,276.35 | 3.06M |
Scheduled
|
Sep 12
| ||
Form 4
| -1.58% | -50.00K |
$175.77 | -$8,788,061.50 | 3.11M |
Scheduled
|
Jun 11
| ||
Form 4
| -1.56% | -50.00K |
$170.96 | -$8,547,718.98 | 3.16M |
Scheduled
|
Mar 11
| ||
Form 4
| +0.34% | 10.74K |
$163.08 | -$1,509,468.48 | 3.21M |
Feb 28 - Feb 29
| |||
Form 4
| -0.15% | -2.35K |
$157.00 | -$369,421.00 | 1.57M |
Feb 26
| |||
Form 4
| -1.53% | -50.00K |
$105.67 | -$5,283,290.75 | 3.21M |
Scheduled
|
Dec 11
| ||
Form 4
| -1.51% | -50.00K |
$127.23 | -$6,361,680.43 | 3.26M |
Sep 11
| |||
Form 4
| -1.49% | -50.00K |
$116.20 | -$5,809,889.11 | 3.31M |
May 31
| |||
Form 4
| -1.47% | -50.00K |
$87.65 | -$4,382,424.02 | 3.36M |
Apr 17
| |||
Form 4
| -0.18% | -3.06K |
$78.46 | -$239,852.22 | 1.67M |
Feb 26 - Feb 28
| |||
Form 4
| -1.44% | -50.00K |
$80.79 | -$4,039,743.71 | 3.42M |
Scheduled
|
Jan 17 - Jan 18
| ||
Form 4
| -0.22% | -7.69K |
$80.09 | -$615,525.18 | 3.47M |
Scheduled
|
Jan 4
| ||
Form 4
| -0.56% | -19.42K |
$80.35 | -$1,560,411.25 | 3.47M |
Scheduled
|
Dec 29 - Jan 3
| ||
Form 4
| -0.60% | -21.10K |
$80.10 | -$1,689,985.68 | 3.49M |
Scheduled
|
Dec 16
| ||
Form 4
| -0.00% | -4.00 |
$80.01 | -$320.04 | 1.79M |
Scheduled
|
Nov 23
| ||
Form 4
| -0.05% | -1.79K |
$80.05 | -$143,201.22 | 3.51M |
Scheduled
|
Nov 8
| ||
Form 4
| -1.40% | -50.00K |
$81.18 | -$4,058,825.33 | 3.52M |
Scheduled
|
Aug 5
| ||
Form 4
| -0.19% | -3.28K |
$62.50 | -$205,125.00 | 1.75M |
Feb 26 - Feb 28
| |||
Form 4
| -66.67% | -100.00K |
$70.50 | -$7,050,000.00 | 50K |
Dec 10
| |||
Form 4
| +1.55% | 28.4K |
—
|
—
| 1.86M |
Feb 26
| |||
Form 4
| -2.65% | -50.00K |
$46.37 | -$2,318,629.20 | 1.84M |
Scheduled
|
Sep 15 - Sep 17
| ||
Form 4
| -2.58% | -50.00K |
$43.50 | -$2,174,774.96 | 1.89M |
Scheduled
|
Jun 15
| ||
Form 4
| -0.79% | -15.40K |
$40.49 | -$623,411.71 | 1.94M |
Scheduled
|
Mar 16 - Mar 18
| ||
Form 4
| -2.50% | -50.00K |
$62.04 | -$3,101,953.96 | 1.95M |
Scheduled
|
Dec 16 - Dec 18
| ||
Form 4
| +1.26% | 25K |
$20.00 | $500,000.00 | 2M |
Oct 18
| |||
Form 4
| +1.28% | 25K |
$11.02 | $275,609.26 | 1.98M |
Jun 5 - Jun 6
| |||
Form 4
| +0.84% | 16.21K |
—
|
—
| 1.95M |
Jun 1
| |||
Form 4
| +11.56% | 212.16K |
$10.00 | $1,000,000.00 | 2.05M |
Sep 22
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
INTREXON CORP (PGEN) Snapshot price: $0.9622
SVP--Product Development
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +34.90% | 29.31K |
$6.88 | $201,680.32 | 113.31K |
Jan 28 - Jan 29
| |||
Form 4
| -33.23% | -20.90K |
$35.66 | -$745,370.97 | 42K |
Dec 2 - Dec 4
| |||
Form 4
| +401.91% | 84K |
$7.12 | $598,080.00 | 104.9K |
May 18
| |||
Form 4
|
∞
| 20.9K |
$14.21 | $297,022.44 | 20.9K |
May 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||